<?xml version="1.0" encoding="UTF-8"?>
<ack>
 <title>ACKNOWLEDGMENTS</title>
 <p>This work was sponsored by the National Institute of Allergy and Infectious Diseases (NIAID) under cooperative agreement numbers UM1-AI068619, UM1-AI068617, and UM1-AI068613 and funded by the U.S. Presidentâ€™s Emergency Plan for AIDS Relief (PEPFAR), the International Initiative for Impact Evaluation (with support from the Bill &amp; Melinda Gates Foundation), NIAID, the National Institute of Mental Health (NIMH), and the National Institute on Drug Abuse (NIDA). E.B. was funded by the Medical Research Council UK and the Oxford NIHR Biomedical Research Centre and is an NIHR Senior Investigator.</p>
 <p>We thank Monique Andersson and the John Radcliffe Hospital, Oxford, Clinical Microbiology Department for assistance with viral load testing.</p>
 <p>We acknowledge the support of the HPTN 071 (PopART) study team and Zambian Ministry for Health.</p>
 <p>Sequencing was supported by the Oxford Viromics initiative (Paul Klenerman, David Bonsall, and Rory Bowden) and the Oxford Genomics Centre (With thanks to John Broxholme, Lorne Lonie, Angie Green, Jerome Nicod, and David Buck). Sample and data collection have been supported by the PANGEA HIV consortium, funded by the Bill &amp; Melinda Gates Foundation.</p>
</ack>
